iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

12 Months Ended

Jun. 30, 2014

Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]

The following table summarizes all warrant activity for the years ended June 30, 2014 and 2013:

	Warrants		Weighted- average Exercise Price
Outstanding as of July 1, 2012		20,940,796	$	1.39
Granted – consulting services		100,000	$	1.00	(1)
Granted – April 2013 equity offering		3,570,000	$	0.53
Granted – Anti-dilution adjustment on August 2008 warrants		785,144	$	1.75
Outstanding as of June 30, 2013		25,395,940	$	1.23	(2)
Exercised		(7,750,000)	$	0.40
Expired		(8,876,029)	$	1.18
Outstanding as of June 30, 2014		8,769,911	$	1.38

Exercisable as of June 30, 2014		8,769,911	$	1.38

(1) See Note 13 – Share-based Compensation.

(2) Includes the effect of reduction in exercise price for previously granted August 2008 warrants.

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details